IRIS
FRANZESE, Ciro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.959
AS - Asia 5.626
EU - Europa 1.698
SA - Sud America 1.391
AF - Africa 274
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.982
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.810
SG - Singapore 3.382
BR - Brasile 1.126
CN - Cina 939
VN - Vietnam 655
FI - Finlandia 298
DE - Germania 290
IE - Irlanda 234
IT - Italia 215
HK - Hong Kong 157
NG - Nigeria 154
FR - Francia 125
GB - Regno Unito 114
IN - India 107
AR - Argentina 101
NL - Olanda 86
SE - Svezia 85
CA - Canada 79
RU - Federazione Russa 58
BD - Bangladesh 56
EC - Ecuador 44
ID - Indonesia 43
TR - Turchia 42
MX - Messico 40
CO - Colombia 35
ZA - Sudafrica 34
IQ - Iraq 32
IL - Israele 28
PL - Polonia 27
CL - Cile 26
ES - Italia 26
VE - Venezuela 26
AU - Australia 24
UA - Ucraina 23
UZ - Uzbekistan 21
BE - Belgio 20
PK - Pakistan 19
SA - Arabia Saudita 18
MA - Marocco 16
AT - Austria 15
KE - Kenya 14
PY - Paraguay 14
EG - Egitto 13
JP - Giappone 13
RO - Romania 13
CZ - Repubblica Ceca 12
TN - Tunisia 12
PE - Perù 11
AZ - Azerbaigian 10
DZ - Algeria 10
KZ - Kazakistan 10
LT - Lituania 10
MY - Malesia 10
OM - Oman 10
JO - Giordania 9
NP - Nepal 9
AE - Emirati Arabi Uniti 8
PH - Filippine 8
A2 - ???statistics.table.value.countryCode.A2??? 6
AL - Albania 6
HN - Honduras 6
IR - Iran 6
PS - Palestinian Territory 6
BG - Bulgaria 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
GR - Grecia 5
NO - Norvegia 5
BO - Bolivia 4
GE - Georgia 4
HR - Croazia 4
SN - Senegal 4
AM - Armenia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
ET - Etiopia 3
EU - Europa 3
KG - Kirghizistan 3
PA - Panama 3
PT - Portogallo 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
JM - Giamaica 2
KH - Cambogia 2
LB - Libano 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
TZ - Tanzania 2
BS - Bahamas 1
Totale 16.961
Salva come PNG Salva come JPEG
Città #
Singapore 1.503
Wilmington 1.080
Dallas 944
Chandler 761
Ashburn 528
The Dalles 476
San Mateo 411
Shanghai 401
San Jose 371
Helsinki 296
Ann Arbor 287
Dublin 232
Ho Chi Minh City 226
Beijing 216
Leawood 198
Boardman 196
Lawrence 186
Princeton 186
Hanoi 157
Benin City 153
New York 151
Hong Kong 132
Woodbridge 121
Falkenstein 118
Fairfield 107
São Paulo 102
Paris 96
Los Angeles 80
Milan 77
Santa Clara 72
Amsterdam 69
London 53
Buffalo 46
Rio de Janeiro 44
Toronto 37
Orem 34
Seattle 34
Da Nang 31
Belo Horizonte 27
Chennai 27
Haiphong 27
Norwalk 27
Kocaeli 25
Porto Alegre 20
Warsaw 20
Brussels 18
Phoenix 17
Tashkent 17
Brasília 16
Curitiba 16
Fortaleza 16
Guayaquil 16
Mexico City 16
Monmouth Junction 16
Munich 16
Naples 16
San Diego 16
Charlotte 15
Johannesburg 15
Montreal 15
Can Tho 14
Brooklyn 13
Council Bluffs 13
Moscow 13
Ribeirão Preto 13
Tokyo 13
Baghdad 12
Biên Hòa 12
Chicago 12
Dhaka 12
Hải Dương 12
Manchester 12
Pune 12
Boston 11
Des Moines 11
Hillsboro 11
Milwaukee 11
Nairobi 11
Quito 11
Stockholm 11
Madrid 10
Ninh Bình 10
Salvador 10
Santo André 10
Baku 9
Bogotá 9
Guarulhos 9
Nova Iguaçu 9
Nuremberg 9
Phủ Lý 9
San Francisco 9
Thái Bình 9
Thái Nguyên 9
Asunción 8
Campinas 8
Cape Town 8
Denver 8
Duque de Caxias 8
Frankfurt am Main 8
Joinville 8
Totale 11.043
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 754
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 141
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 130
Accuracy of fine-needle aspiration cytology in detecting cervical node metastasis after radiotherapy: Systematic review and meta-analysis 122
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature 120
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 113
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 113
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 112
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 111
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group 109
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 108
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 108
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 101
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 100
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 100
Concomitant adjuvant chemo-radiation therapy with anthracyclinebased regimens in breast cancer: a single centre experience 100
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 99
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 99
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 97
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer 95
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 94
Management of inflammatory breast cancer: Focus on radiotherapy with an evidence-based approach 93
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 91
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 90
Hypofractionated stereotactic radiation therapy in skull base meningiomas 89
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 88
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 88
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 88
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 86
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 85
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival 85
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 85
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 83
Adenoid cystic carcinoma of the breast The double face of an exocrine gland carcinoma 82
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 82
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 81
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 81
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 79
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 79
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 78
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 78
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series 77
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 76
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis 76
Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients. 76
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 75
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients 74
RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER: RESULTS OF EFFICACY AND SAFETY 74
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 74
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 74
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 74
RapidPlan head and neck model: the objectives and possible clinical benefit. 73
Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy. 73
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study 73
Results of a feed-back learning process for RapidPlan knowledge based planning 72
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 72
Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer. 72
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 72
Imaging biomarkers in primary brain tumours 72
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 71
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 71
Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. 71
The role of SBRT in oligometastatic patients with liver metastases from breast cancer 71
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 71
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution 71
Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? 71
Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis 70
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 70
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 70
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 70
HYPOFRACTIONATED RADIATION THERAPY (OVER 3 WEEKS) CAN REPLACE CONVENTIONAL RADIATION THERAPY SCHEDULE (OVER 6 WEEKS) IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS? THE TIMES ARE RIPE 70
SBRT for oligometastatic gynecological cancer: a single institution experience 69
Role of preoperative radiotherapy in rare retroperitoneal sarcoma 69
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome 69
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up 69
Stereotactic Body Radiation Therapy for oligometastatic patients with ovarian cancer 69
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study 69
Role of extra cranial stereotactic body radiation therapy in the management of Stage IV melanoma 68
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 68
Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy. 68
SABR in inoperable liver oligometastatic patients and radioresistant primary tumors 68
Oligoscore: a clinical score to predict overall survival in patients with oligometastatic disease treated with stereotactic body radiotherapy 67
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 67
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 67
LINAC-BASED STEREOTACTIC RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: 4-YEAR FOLLOW-UP UPDATE ON TOXICITY AND SURVIVAL 67
Role of C-11-CHOLINE PET/CT in the Radiotherapy Treatment Planning of Prostate Cancer Patients 67
Oligometastatic colorectal cancer in elderly patients: role of stereotactic body radiation therapy 67
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis 67
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors 66
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO‐Head and Neck working group 66
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 66
Hypofractionated radiotherapy for ductal carcinoma in situ using VMAT: acute toxicity and cosmesis 66
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy 66
Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question 65
Stereotactic Body Radiation Therapy in Oligometastatic Ovarian Cancer A Promising Therapeutic Approach 65
Low Prevalence of K-RAS, EGF-R and BRAF Mutations in Sinonasal Adenocarcinomas. Implications for Anti-EGFR Treatments 65
Role of SBRT in the treatment of liver metastases: clinical results and prognostic factors 65
Influence of "radioresistant" histologies on SBRT outcome for lung metastases 65
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy. 64
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy. 64
Totale 8.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021202 0 0 0 0 0 0 0 0 0 0 0 202
2021/2022983 62 7 8 217 6 4 42 150 88 89 278 32
2022/20232.300 401 84 230 242 192 163 1 173 405 229 162 18
2023/20241.463 72 167 327 80 45 145 58 70 70 32 152 245
2024/20252.459 51 89 33 33 23 276 121 226 381 644 254 328
2025/20267.972 1.025 610 1.003 1.060 214 289 1.819 559 434 431 283 245
Totale 17.207